WS17.02 Long-term efficacy of lumacaftor/ivacaftor (LUM/IVA) in children aged 2 through 5 years with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation (F/F): a phase 2, open-label extension study

Autor:	M. Stahl, J. Roehmel, M. Eichinger, F. Doellinger, L. Naehrlich, M.V. Kopp, A.-M. Dittrich, O. Sommerburg, P. Ray, A. Maniktala, M.E. Duncan, T. Xu, P. Wu, A. Joshi, M. Mascia, S. Tian, M.O. Wielpütz, M.A. Mall
Rok vydání:	2022
Předmět:	Pulmonary and Respiratory Medicine Pediatrics Perinatology and Child Health
Zdroj:	Journal of Cystic Fibrosis. 21:S32-S33
ISSN:	1569-1993
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b3f0cbc57ff79b500b13070234d72317 https://doi.org/10.1016/s1569-1993(22)00250-8 Zobrazit plný text záznamu Full Text from ScienceDirect